Released Jul 22, 2025, after the close
10-Q filed Jul 23, 2025, 23 days after period end · 0001035267-25-000192
Q2 2025 · 10-Q
Revenue$2.44B$2.44B +21.4% vs Q2 2024+8.3% vs Q1 2025
Net Income$658.40M$658.40M +25.0% vs Q2 2024−5.7% vs Q1 2025
EPS Diluted$1.81$1.81 +24.0% vs Q2 2024−5.7% vs Q1 2025
Gross Profit$1,617,900,000+17.9%
Operating Income$743,400,000+31.0%
Operating Cash Flowderived$715,400,000+15.3%
Free Cash Flowderived$560,100,000+80.0%
Margins · derived
Gross margin66.3%−2.0 pt vs Q2 2024
Operating margin30.5%+2.2 pt vs Q2 2024
Net margin27.0%+0.8 pt vs Q2 2024
What the release said
The release
Same quarter
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Revenue | $2.44B | $2.01B | $1.76B | $1.52B |
| Net Income | $658.40M | $526.90M | $420.80M | $307.80M |
| EPS Diluted | $1.81 | $1.46 | $1.18 | $0.85 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Intuitive Surgical Inc · CIK 1035267 · Engraved from SEC EDGAR